Featured Research

from universities, journals, and other organizations

Anthrax Survivors Continued To Have Health Problems One Year After Exposure

Date:
April 28, 2004
Source:
Journal Of The American Medical Association
Summary:
People infected with anthrax continued to report health problems, poor life adjustment, and psychological distress one year after their exposure, according to a study in the April 28 issue of The Journal of the American Medical Association (JAMA).

People infected with anthrax continued to report health problems, poor life adjustment, and psychological distress one year after their exposure, according to a study in the April 28 issue of The Journal of the American Medical Association (JAMA).

In 2001, bioterrorist activities involving the U.S. Postal Service infected 22 individuals with Bacillus anthracis (anthrax), according to background information in the article. Six survivors had inhalational anthrax and 11 cutaneous anthrax disease. Little is known about potential long-term health effects of bioterrorism-related anthrax infection.

Dori B. Reissman, M.D., M.P.H., of the Centers for Disease Control and Prevention, Atlanta, and colleagues conducted a cross-sectional health assessment approximately 1 year after the 2001 onset of anthrax infection to better characterize the somatic (affecting the body) symptoms, health status, and functional capacity of the bioterrorism-related anthrax survivors.

The study included assessment of 15 of 16 adult survivors from September through December 2002 using a clinical interview, a medical review-of-system questionnaire, 2 standardized self-administered questionnaires, and a review of available medical records.

The researchers found that the anthrax survivors reported symptoms affecting multiple body systems, significantly greater psychological distress, and significantly reduced health-related quality-of-life indices compared with U.S. referent populations. "Eight survivors (53 percent) had not returned to work since their infection. Comparing disease manifestations, inhalational survivors reported significantly lower overall physical health than cutaneous survivors. Available medical records could not explain the persisting health complaints," the authors write.

The most common health complaints included respiratory tract problems (e.g., chronic cough), fatigue, joint complaints (e.g., swelling, pain), and cognitive impairment (e.g., memory problems). The most frequently reported psychological distress symptoms included depression, anxiety, obsessive-compulsive, and hostility.

The researchers write that these finding are "similar to findings reported after exposure to other types of traumatic events and highlights the importance of measuring these dimensions as standard practice. Many factors may contribute to the distress variance reported by the anthrax survivors, including differences in exposure characteristics, sociocultural and occupational considerations, and perceived inequities of case management."

"Our findings support those of other studies in the United States in which terrorism has led to significant chronic physical and mental health problems. Standard assessment of terrorism survivors should include medically unexplained health complaints and psychiatric comorbidity, such as symptoms of posttraumatic stress disorder, depression, and anxiety disorders. Psychiatric and medical systems of care and rehabilitation should be coordinated to minimize functional impairment and improve health-related quality of life," the authors conclude.

###

(JAMA. 2004;291:1994-1998. Available post-embargo at JAMA.com)

Editor's Note: The Centers for Disease Control and Prevention funded this work.


Story Source:

The above story is based on materials provided by Journal Of The American Medical Association. Note: Materials may be edited for content and length.


Cite This Page:

Journal Of The American Medical Association. "Anthrax Survivors Continued To Have Health Problems One Year After Exposure." ScienceDaily. ScienceDaily, 28 April 2004. <www.sciencedaily.com/releases/2004/04/040428062532.htm>.
Journal Of The American Medical Association. (2004, April 28). Anthrax Survivors Continued To Have Health Problems One Year After Exposure. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2004/04/040428062532.htm
Journal Of The American Medical Association. "Anthrax Survivors Continued To Have Health Problems One Year After Exposure." ScienceDaily. www.sciencedaily.com/releases/2004/04/040428062532.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins